Indian state regulator suspends manufacture of drug at Wockhardt plant
Indian authorities have suspended the manufacture of a Wockhardt fixed dose combination drug, the company has announced in a filing.
Archives for April 23, 2014
Biogen Idec selects Quintiles in 5-year strategic partnership
Biogen Idec’s five-year deal is the latest example of biopharma embracing the strategic partnership model, but the choice of Quintiles is somewhat of a surprise, according to ISI analyst Ross Muken.
Japanese pharma using more CROs as large-scale development picks up
A new report says the Japanese CRO market is seeing more growth as Japanese pharma firms, which traditionally kept research in-house, are now broadening their horizons to use more outsourcing partners.
SAS platform used to share big pharma cancer trial data
SAS, a provider of tools for data and health analysis, will supply the platform for a project sharing oncology data from studies by AstraZeneca, Janssen R&D, Pfizer and Sanofi.
EC-pharma research collaboration could provide opportunities for CROs
CROs could benefit from a €3bn ($4.1bn) research programme run jointly by the European Commission and the pharmaceutical industry, according to ACRO.
Opko acquires Israeli-made dry powder inhaler to treat respiratory disorders
Opko Health has agreed to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases.